Clinical Trials Directory

Trials / Completed

CompletedNCT00825786

Ultrasound Guided Supraclavicular Nerve Block

Ultrasound Guided Supraclavicular Nerve Block: Comparison Between a Mixture of Mepivacaine and Ropivacaine, and Sequential Injection of Mepivacaine Followed by Ropivacaine

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
103 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.

Detailed description

Patients will be randomized into one of two groups, Group M: Ropivacaine and Mepivacaine - subject will receive two injections before surgery begins. These two injections will consist of the mixture of mepivacaine (15 ml) and ropivacaine (15 ml). Group S: Mepivacaine followed by Ropivacaine. Subjects will receive two injections before surgery begins. One injection will contain mepivacaine (15 ml) and the other will contain ropivacaine (15 ml). On the first, second, and third mornings after surgery,subjects will be asked to rate their pain on a scale of 1 to 10. If the subject is discharged from the hospital, a telephone call will be made to the subject's home to collect this information.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineropivacaine (15 ml).
DRUGMepivacaineOne syringe will contain mepivacaine (15 ml)

Timeline

Start date
2008-09-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2009-01-21
Last updated
2017-06-14
Results posted
2017-04-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00825786. Inclusion in this directory is not an endorsement.